在常规筛查的劳动力中，BNT162b2 疫苗接种后的无症状和有症状 SARS-CoV-2 感染。
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
机构信息
Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
出版信息
JAMA. 2021 Jun 22;325(24):2500-2502. doi: 10.1001/jama.2021.6564.
Abstract
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.
摘要
本研究旨在描述辉瑞-生物科技（BNT162b2）疫苗与医院员工中症状性和无症状性 SARS-CoV-2 感染风险降低之间的关联。
相似文献
1
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
JAMA. 2021 Jun 22;325(24):2500-2502. doi: 10.1001/jama.2021.6564.
2
Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.
Ann Intern Med. 2021 Dec;174(12):1770-1772. doi: 10.7326/M21-3486. Epub 2021 Oct 19.
3
Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination.
JAMA Netw Open. 2021 Jul 1;4(7):e2115980. doi: 10.1001/jamanetworkopen.2021.15980.
4
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
N Engl J Med. 2021 Jul 29;385(5):474-476. doi: 10.1056/NEJMc2104849. Epub 2021 May 19.
5
Mass screening of healthcare personnel for SARS-CoV-2 in the Northern Emirates.
J Hosp Infect. 2021 Feb;108:52-54. doi: 10.1016/j.jhin.2020.10.008. Epub 2020 Oct 17.
6
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
Emerg Microbes Infect. 2021 Dec;10(1):1254-1256. doi: 10.1080/22221751.2021.1942230.
7
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
Antimicrob Resist Infect Control. 2021 Feb 27;10(1):44. doi: 10.1186/s13756-021-00912-z.
8
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
9
Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations.
JAMA Netw Open. 2020 Dec 1;3(12):e2031517. doi: 10.1001/jamanetworkopen.2020.31517.
10
Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination.
JAMA Netw Open. 2021 Sep 1;4(9):e2125394. doi: 10.1001/jamanetworkopen.2021.25394.
引用本文的文献
1
SARS-CoV-2 seroprevalence screening study of a children's hospital health care workers.
J Infect Prev. 2024 Nov;25(6):206-213. doi: 10.1177/17571774241245260. Epub 2024 Apr 14.
2
The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data.
Vaccines (Basel). 2024 Feb 11;12(2):182. doi: 10.3390/vaccines12020182.
3
Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.
J Appl Lab Med. 2023 Sep 7;8(5):871-886. doi: 10.1093/jalm/jfad042.
4
Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February-December 2021.
IJID Reg. 2023 Sep;8:19-27. doi: 10.1016/j.ijregi.2023.04.009. Epub 2023 Apr 16.
5
Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers.
J Clin Med. 2023 Apr 28;12(9):3172. doi: 10.3390/jcm12093172.
6
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2219523120. doi: 10.1073/pnas.2219523120. Epub 2023 Mar 9.
7
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2.
Am J Epidemiol. 2023 Jun 2;192(6):1016-1028. doi: 10.1093/aje/kwad046.
8
Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks.
Front Immunol. 2023 Feb 13;14:1049393. doi: 10.3389/fimmu.2023.1049393. eCollection 2023.
9
Epidemiology and Clinical Presentation of COVID-19 in Older Adults.
Infect Dis Clin North Am. 2023 Mar;37(1):1-26. doi: 10.1016/j.idc.2022.11.001. Epub 2022 Nov 4.
10
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave.
Int J Infect Dis. 2023 Mar;128:347-354. doi: 10.1016/j.ijid.2023.01.023. Epub 2023 Jan 22.
本文引用的文献
1
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
2
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy.
Bull World Health Organ. 1988;66(1):99-105.
Zotero 插件